Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biochaperone Combo PK/PD Clamp Study in Type 2 Diabetes
NCT02514850Phase 1Completed
- Sponsor
- Adocia
- Start
- Jul 2015
- Primary completion
- Nov 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BioChaperone glargine lispro in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Adocia. Primary endpoint: Area under the glucose infusion rate curve 12-30h. Started Jul 2015; status: completed.
02
Drugs
BioChaperone glargine lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02514850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02514850.